Ev3, FoxHollow sign peripheral artery disease alliance
Executive Summary
Ev3 (catheter-based devices for cardiovascular diseases) and FoxHollow Technologies (minimally invasive devices to remove plaque and thrombus) have teamed up to jointly study the former's SpideRx embolic protection devices with the latter's RockHawk calcium cutting device as a treatment for calcified lesions in patients with peripheral artery disease.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice